Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

AACR 2023 | The use of artificial intelligence in oncology

Sarah Fremond • 17 Apr 2023
AACR 2023
General

Sarah Fremond, Leiden University Medical Centre, Leiden, The Netherlands, comments on the field of artificial intelligence (AI) discussed at AACR 2023, highlighting how although some AI model predictions may not be able to be validated focus should be directed towards the production of tools to decipher whether the models prediction is confident. This interview took place at the American Association for Cancer Research (AACR) Annual Meeting 2023 in Orlando, FL.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Sarah Fremond

1:15
The challenges with AI in oncology for predicting risk of distant recurrence
Sarah Fremond • 17 Apr 2023
1:10
Deep learning risk prediction model of distant recurrence from H&E endometrial cancer slides
Sarah Fremond • 17 Apr 2023

Related Videos

2:03
Biomarker detection for early cancer detection
Robert Rintoul • 19 Apr 2024
0:29
Innovative ctDNA-based liquid biopsy techniques for cancer diagnosis
Alain Thierry • 9 Apr 2024
0:50
Employing fragmentomics as a novel strategy to characterize and detect cancers
Alain Thierry • 9 Apr 2024
1:27
Emerging trials in melanoma: SWOG S1801, OpACIN-neo and PRADO
Christoffer Gebhardt • 9 Apr 2024
The content of VJOncology is intended for healthcare professionals